A platelet count of 10 X 109/L or greater usually provides adequate hemostasis. Platelet transfusions are associated with adverse events and risks. Considerations in the decision to transfuse platelets include the cause of the thrombocytopenia, comorbid conditions, symptoms of bleeding, risk factors for bleeding, and the need to perform an invasive procedure.
Conditions: Chemotherapy-Induced Thrombocytopenia, Low Platelet Count
Treatments: Platelet Transfusion
View PDF
Sources
- Estcourt L, Stanworth S, Doree C, et al. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev. 2012;5:Cd004269. (PubMed)
- Guidelines for the use of platelet transfusions. Br. J. Haematol. Jul 2003;122(1):10-23. (PubMed)
- Slichter SJ, Kaufman RM, Assmann SF, et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N. Engl. J. Med. Feb 18 2010;362(7):600- 613. (PubMed)
- Szczepiorkowski ZM, Dunbar NM. Transfusion guidelines: when to transfuse. Hematology Am. Soc. Hematol. Educ. Program. 2013;2013:638-644. (PubMed)